Pfizer-backed VitaDAO spins out biotech company

VitaDAO, which funds longevity research, announced the $300,000 financing of a biotechnology company, the DAO’s first such investment

article-image

PowerUp/Shutterstock modified by Blockworks

share

VitaDAO is announcing the launch of Matrix Biosciences, a biotechnology company led by University of Rochester anti-aging researcher Vera Gorbunova. The launch comes with $300,000 in initial financing, with more funding to come in early 2024. 

The company will expand on Gorbunova’s research on the long life spans and cancer resistance of naked mole rats and examine whether a compound found in the rats could improve human lifespan.

Launched in 2021, VitaDAO funds “longevity” research aimed at extending human life. The DAO currently funds 20 projects, primarily focused on potential “moonshot” contributions to longevity science. Todd White, a VitaDAO core contributor, compared the DAO to an endowment fund, because members don’t take a profit from the research and all revenue is sent to the DAO treasury to fund other projects.

The DAO closed a $4 million funding round earlier this year, headlined by an investment from Pfizer Ventures.

VitaDAO invests in “valley of death”-stage ideas where research is still unproven, White said, adding that Pfizer once put significant resources into an early-stage investment team but judged such investments too risky before investing in VitaDAO.

“They realized we were doing what they were trying to do, but we were doing it better and at a fraction of the cost. And so this was kind of this real sort of Web3 awakening for Pfizer,” White said.

Being a community of researchers, VitaDAO has positioned itself within the “decentralized science” movement and a growing interest in DAOs as research funding tools. 

White said the DAO has struggled to ingratiate itself into the university milieu as blockchain technology struggles to rehab its image in the wake of the FTX collapse. But White feels like the niche field of longevity research shares an ethos with crypto.

Both worlds believe “we’re not going to go through this traditional thing. This is stupid. There’s a whole bunch of impediments here,” White said. “We’re retesting all the original assumptions.”


Get the news in your inbox. Explore Blockworks newsletters:

Tags

Decoding crypto and the markets. Daily, with Byron Gilliam.

Upcoming Events

Old Billingsgate

Mon - Wed, October 13 - 15, 2025

Blockworks’ Digital Asset Summit (DAS) will feature conversations between the builders, allocators, and legislators who will shape the trajectory of the digital asset ecosystem in the US and abroad.

recent research

Unlocked by Template (10).png

Research

Innovations on Aptos’ technical design through Raptr, Shardines, and Zaptos approach near-optimal latency and throughput by unlocking 100% utilization of network resources, with the capacity to settle 260k transactions per second with latencies less than 800ms. The original Move language was revamped with the launch of Move 2, supporting more expressivity in smart contract logic and a scalable ability to interact with high volume datasets. The ecosystem has benefitted from strong asset inflows, now hosting over $1.3B in stablecoins, $450M in bridged BTC, and $530M in RWAs. Activity in the Aptos ecosystem has grown notably over the past year, with monthly application revenue reaching ~$835k and monthly DEX volumes growing to over $5B, both at new all time highs.

article-image

Interchain Labs will focus on sovereign L1s and institutional demand, abandoning plans for smart contracts on the Cosmos Hub

article-image

Also, only three tokens have outperformed bitcoin so far this year: XMR, HYPE and SKY

article-image

The fund group has submitted proposals in recent months for other funds that would hold litecoin, solana, XRP, HBAR, Sui and others

article-image

Momentum’s back — BTC leads, risk assets follow

article-image

Ondo Finance’s acquisition of blockchain development company Strangelove follows its buy of Oasis Pro

article-image

Cryptocurrency and stock traders alike had a lot to unpack Wednesday